Report: Combination of health goods risky

Jul 22, 2007

A study in Canada has found the health industry has not adequately recognized the danger of pairing natural health products with prescription medication.

Research conducted at the University of Alberta featuring 132 pharmacists found that while nearly half had patients with possible side effects from the health combination, just 1.5 percent reported them to Canadian health officials, a release said Friday.

"The data show that adverse events are not being reported or are being under-reported at a dramatic rate," co-author of the study, Dr. Sunita Vohra, said. "Natural health products should be treated with due respect."

Vohra did point out that such harmful occurrences only represented a small portion of the overall use of natural health products in Canada.

The natural health products focused on in the study included vitamins, garlic, St. John's wort, Echinacea and minerals probiotics.

The group suggested using active surveillance and offering customers additional information to avoid such potentially harmful interactions.

Copyright 2007 by United Press International

Explore further: Expression of privilege in vaccine refusal

add to favorites email to friend print save as pdf

Related Stories

Study to inform Maryland decision on "fracking"

Aug 20, 2014

The Maryland Department of Environment and Department of Health and Mental Hygiene released on August 18, 2014, a report by the University of Maryland School of Public Health, which assesses the potential ...

Recommended for you

Expression of privilege in vaccine refusal

6 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments : 0